Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Pediatrics, |
RCV001256500 | SCV001478119 | likely pathogenic | Fanconi anemia complementation group A | 2020-12-15 | criteria provided, single submitter | research | |
Invitae | RCV001879793 | SCV002218142 | pathogenic | Fanconi anemia | 2023-09-21 | criteria provided, single submitter | clinical testing | This variant, c.2604_2609del, results in the deletion of 2 amino acid(s) of the FANCA protein (p.Gln869_Phe870del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs745864224, gnomAD 0.0009%). This variant has been observed in individual(s) with clinical features of Fanconi anemia (PMID: 15643609, 17924555). ClinVar contains an entry for this variant (Variation ID: 974247). This variant disrupts a region of the FANCA protein in which other variant(s) (p.Gln869Pro) have been determined to be pathogenic (PMID: 15643609, 17924555, 29098742; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001256500 | SCV004196603 | likely pathogenic | Fanconi anemia complementation group A | 2022-11-29 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV001256500 | SCV001425965 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Daniela Pilonetto, Johan de Winter. |